Literature DB >> 6185144

Characterization of a phosphorylated form of the intermediate filament-aggregating protein filaggrin.

J D Lonsdale-Eccles, D C Teller, B A Dale.   

Abstract

Filaggrin and a phosphorylated form of filaggrin, which has been shown by pulse-chase studies to be a precursor form of the protein [Dale, B. A., & Ling, S. Y. (1979) Biochemistry 18, 3539-3546], were compared for functional, biochemical, and physical properties. Filaggrin reacts with keratin filaments to form visible macrofibrils, unlike the precursor which does not. Biochemical and peptide-mapping studies suggest that the two proteins have similar, perhaps identical, amino acid sequences. The major differences between the two proteins are in molecular weight (precursor, 44 200 g/mol; filaggrin, 38 400 g/mol), the existence of oligomeric forms of the precursor, and the presence of phosphate in the precursor (15-20 mol/mol of protein). Phosphoserine was identified in the precursor, but neither phosphothreonine nor phosphotyrosine was observed. The results of proteolytic digests of [32P]phosphate-radiolabeled precursor show that the phosphate is unevenly distributed throughout the molecule and may be localized in approximately 30% of the precursor. A discrete localization of the phosphate in the precursor may block a specific keratin filament combining site and so prevent premature aggregation of these filaments during epidermal differentiation. It is suggested that a specific phosphatase is involved in the dephosphorylation, because several phosphatases of general specificity, including rat epidermal lysosomal acid phosphatase, did not catalyze this conversion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6185144     DOI: 10.1021/bi00266a033

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.

Authors:  M Simon; E Girbal; M Sebbag; V Gomès-Daudrix; C Vincent; G Salama; G Serre
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

2.  Keratohyalin granules are heterogeneous in ridged and non-ridged human skin: evidence from anti-filaggrin immunogold labelling of normal skin and skin of autosomal dominant ichthyosis vulgaris patients.

Authors:  S Günzel; B Weidenthaler; I Hausser; I Anton-Lamprecht
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

3.  Epidermal proteins. I. Differential extraction and quantitative polyacrylamide gel-electrophoretic analysis of basal spinous-cell proteins of neonatal mouse epidermis.

Authors:  R S Labib; G J Anhalt; H P Patel; L A Diaz
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

4.  Quantitative phosphoproteomics identifies filaggrin and other targets of ionizing radiation in a human skin model.

Authors:  Feng Yang; Katrina M Waters; Bobbie-Jo Webb-Robertson; Marianne B Sowa; Claere von Neubeck; Josh T Aldrich; Lye Meng Markillie; Rachel M Wirgau; Marina A Gritsenko; Rui Zhao; David G Camp; Richard D Smith; David L Stenoien
Journal:  Exp Dermatol       Date:  2012-05       Impact factor: 3.960

5.  Peptidylarginine Deiminase Inhibitor Cl-Amidine Attenuates Cornification and Interferes with the Regulation of Autophagy in Reconstructed Human Epidermis.

Authors:  Laura Cau; Hidenari Takahara; Paul R Thompson; Guy Serre; Marie-Claire Méchin; Michel Simon
Journal:  J Invest Dermatol       Date:  2019-03-13       Impact factor: 8.551

Review 6.  Revisiting the Roles of Filaggrin in Atopic Dermatitis.

Authors:  Verena Moosbrugger-Martinz; Corinne Leprince; Marie-Claire Méchin; Michel Simon; Stefan Blunder; Robert Gruber; Sandrine Dubrac
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

7.  Filaggrin in the frontline: role in skin barrier function and disease.

Authors:  Aileen Sandilands; Calum Sutherland; Alan D Irvine; W H Irwin McLean
Journal:  J Cell Sci       Date:  2009-05-01       Impact factor: 5.285

8.  Structural properties of target binding by profilaggrin A and B domains and other S100 fused-type calcium-binding proteins.

Authors:  Alexander J Hinbest; Sa Rang Kim; Sherif A Eldirany; Ivan B Lomakin; Joseph Watson; Minh Ho; Christopher G Bunick
Journal:  J Dermatol Sci       Date:  2020-08-21       Impact factor: 4.563

9.  Is filaggrin really a filament-aggregating protein in vivo?

Authors:  B Weidenthaler; I Hausser; I Anton-Lamprecht
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

10.  Identification of two intermediates during processing of profilaggrin to filaggrin in neonatal mouse epidermis.

Authors:  K A Resing; K A Walsh; B A Dale
Journal:  J Cell Biol       Date:  1984-10       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.